These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23821288)

  • 1. Relationship between estimated glomerular filtration rate and biological half-life of 131I. Retrospective analysis in patients with differentiated thyroid carcinoma.
    Vogel K; Opfermann T; Wiegand S; Biermann J; Busch M; Winkens T; Freesmeyer M
    Nuklearmedizin; 2013; 52(5):164-9. PubMed ID: 23821288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of effective half-life of
    Freesmeyer M; Gühne F; Kühnel C; Opfermann T; Winkens T; Werner A
    Endocrine; 2019 Mar; 63(3):554-562. PubMed ID: 30382554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of 131I therapy for thyroid cancer: cumulative dose from in-patients, discharge planning and personnel requirements.
    Pacilio M; Bianciardi L; Panichelli V; Argirò G; Cipriani C
    Nucl Med Commun; 2005 Jul; 26(7):623-31. PubMed ID: 15942483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I effective half-life (Teff) for patients with thyroid cancer.
    Willegaignon J; Malvestiti LF; Guimarães MI; Sapienza MT; Endo IS; Neto GC; Marone M; Sordi GM
    Health Phys; 2006 Aug; 91(2):119-22. PubMed ID: 16832192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of creatinine based and kidney volume based methods of estimating glomerular filtration rates in potential living kidney donors.
    Goh YS; Wu MW; Tai BC; Lee KC; Raman L; Teo BW; Vathsala A; Tiong HY
    J Urol; 2013 Nov; 190(5):1820-6. PubMed ID: 23770137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
    Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
    Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma.
    Zerva B; Koutsikos J; Palestidis C; Kounadi E; Gerali S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):348-54. PubMed ID: 17043633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic 123I and 131I activities and radioiodine therapy. Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma.
    Meller B; von Hof K; Genina E; Deisting W; Meller J; Richter E; Baehre M
    Nuklearmedizin; 2005; 44(6):243-8. PubMed ID: 16400384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy.
    Willegaignon J; Stabin MG; Guimarães MI; Malvestiti LF; Sapienza MT; Maroni M; Sordi GM
    Health Phys; 2006 Aug; 91(2):123-7. PubMed ID: 16832193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased uptake after fractionated ablative doses of iodine-131.
    Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
    Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
    Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
    Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of GFR estimation formula in determination of glomerular filtration rate in kidney donors: Comparison with 24 h urine creatinine clearance.
    Hafeez AR; Idrees MK; Akhtar SF
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):320-5. PubMed ID: 26997385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.
    Trimarchi H; Muryan A; Martino D; Toscano A; Iriarte R; Campolo-Girard V; Forrester M; Pomeranz V; Fitzsimons C; Lombi F; Young P; Raña MS; Alonso M
    J Nephrol; 2012; 25(6):1003-15. PubMed ID: 22322818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2004 Apr; 45(4):619-25. PubMed ID: 15073258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
    Mitchell T; Hadlow N; Chakera A
    Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biodistribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure.
    Aktaş A; Kavak K; Kocabaş B; Aras M; Tütüncü NB; Gençoğlu A
    Nucl Med Commun; 2008 Nov; 29(11):943-8. PubMed ID: 18836371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.